SLC12A4 promoter methylation in plasma cell-free DNA as a candidate biomarker for thyroid cancer
Background Plasma cell-free DNA (cfDNA) methylation has emerged as a promising non-invasive approach for cancer detection; however, methylation biomarkers for thyroid carcinoma (THCA) remain insufficiently defined. This study aimed to identify THCA-associated DNA methylation alterations and evaluate their potential dia...